WASHINGTON (AP) — When Bangladeshi blogger and social activist Ashif Entaz Rabi hosted a TV talk show about a slaying of a publisher by Islamic extremists, he faced a torrent of threatening phone calls. He says young men with earpieces started loitering outside his workplace, and a militant website urged followers to "send this Ashif to Allah."
More charges related to Shkreli's involvement with biopharmaceutical company Retrophin Inc could be filed within a month, Assistant U.S. Attorney Winston Paes said at a hearing in federal court in Brooklyn, New York. Shkreli, 33, sparked outrage among patients, medical societies and U.S. lawmakers after another company he ran, Turing Pharmaceuticals, raised the price of the drug Daraprim by more than 5,000 percent to $750 a pill. Shkreli has pleaded not guilty, and his lawyer Benjamin Brafman told reporters after Tuesday's court hearing that he did not believe additional charges would change the case.